Consuming fewer than 1,200 calories daily for women or 1,500 for men can lead to nutrient deficiencies, muscle loss, and metabolic complications
Retatrutide represents an extraordinary advance in the field of longevity medicine, addressing obesity and metabolic health through an innovative triple receptor agonist mechanism
Stimulate AMPK to help you lose fat, not muscle
Reports indicate that the incidence correlates with higher dosing, and onset occurs within the first month of therapy and upon dose escalation
Compared to general practice, the more frequent and structured use of RDNs and MNT in these trials could be one reason why these trials demonstrated larger weight reductions than seen in real-world GLP-1 utilization for obesity
Originally used for Type 2 diabetes, these medications are being repurposed for a wider range of health conditions, prompting an evolution in chronic disease treatment paradigms